74
Wang et al.
phenolic aglycone substrates: 4-MU, 4-NP, 1-naphthol, BPA, phase II glucuronosyltransferases. These results provide in-
t-OP, and MPA. 4-MU, a coumarin derivative, has been used sight into the mechanisms by which zebrafish defend them-
safely for many years as a cholagogue and is a promising selves against a vast number of endobiotics and xenobiotics via
therapeutic agent targeting invasion and metastasis of glucuronidation conjugations and lay the foundation for de-
many kinds of tumors via inhibition of hyaluronan synthesis veloping the zebrafish as a model vertebrate in toxicological,
(Kakizaki et al., 2004). 4-NP is a common metabolite from developmental, and pathologic studies.
a variety of compounds and a biomarker of organophosphate
insecticide exposure (Kaivosaari et al., 2011). 1-Naphthol,
Acknowledgments
The authors thank Dr. Ida Owens for advice on investigating UGT
post-translational modification and members of the Wu laboratory
for discussion.
a prime substrate for human UGT1A6, is a precursor to a
variety of insecticides and a prominent component of Molisch’s
reagent. BPA is a monomer for manufacturing polycarbonate
plastics and epoxy resins and can be released during auto-
claving. It has hormone-like activities that disrupt the endocrine
system and increase the risk of obesity (Howdeshell et al., 1999).
Among environmental alkylphenols, t-OP is the most estrogenic
(Routledge and Sumpter, 1997). MPA is the active metabolite of
mycophenolate mofetil, a prodrug used to prevent tissue
rejection after organ transplantation (Wu et al., 2011).
Steroid hormones are mainly metabolized via glucuronida-
tion (James, 2011). In human, steroid hormones are pre-
dominantly glucuronidated by members of the UGT2 family
(Sten et al., 2009). In zebrafish, however, they are mainly
conjugated by members of the UGT5 family (Tables 2 and 3).
UGT5E1 is the principal enzyme responsible for steroid
conjugations, with high activity and affinity toward testos-
terone and E2. The Ugt5e1 gene is expressed in the ex-
trahepatic tissues of the gill, heart, kidney, testis, and eye
(Fig. 1C).
Bilirubin, a major breakdown product of heme catabolism,
is excreted predominantly as glucuronide conjugates in the
bile. In zebrafish, we found that it is conjugated by several
UGT1 enzymes at very low rates. Among them, UGT1B7 has
the highest glucuronidation activity toward bilirubin, mainly
forming the monoglucuronides (Fig. 3J). In addition, we found
that UGT1B7 is specific toward bilirubin, with no detectable
glucuronidation activity toward any of the other nine aglycone
substrates. Moreover, the Ugt1b7 gene is highly expressed in
the liver, which is responsible for bilirubin catabolism.
Diclofenac, a nonsteroidal anti-inflammatory drug widely
used for reducing inflammation and relieving pain, is
primarily eliminated as acyl-glucuronide in mammals (King
et al., 2001). Its acyl-glucuronide forms covalent drug-protein
adducts, possibly contributing to its immunogenicity and
toxicity (King et al., 2001). In zebrafish, UGT1A1 is the only
isozyme that has a high rate of diclofenac glucuronidation
(Table 2). However, kinetic analyses revealed a very high Km
value of UGT1A1 for diclofenac, indicating its low affinity.
In summary, members of the zebrafish Ugt superfamily are
widely expressed in various tissues. In addition, some mem-
bers of the zebrafish UGT5 family have glucuronidation ac-
tivities toward multiple aglycones. Specifically, the zebrafish
UGT5A5 and UGT5E1 predominantly glucuronidate the hor-
mone steroids of E2 and testosterone, and the zebrafish
UGT5B2 glucuronidates t-OP at the highest rate and several
phenols at a lower rate. Thus, UGT5 is a novel UGT family
using UDPGA as the donor. Moreover, some members of the
zebrafish UGT1 family conjugate a wide range of compounds,
including simple phenols, bilirubin, carboxylic acids, coumar-
ins, mycophenolic acid, and bisphenol A. Importantly, each of
these lipophilic compounds is conjugated by at least one
member of the UGT superfamily, confirming that these
diverse 40 UGTs are the entire complement of the zebrafish
Authorship Contributions
Participated in research design: Wang, Huang, Wu.
Conducted experiments: Wang, Huang.
Performed data analysis: Wang, Huang, Wu.
Wrote or contributed to the writing of the manuscript: Wang,
Huang, Wu.
References
Carvan MJ, 3rd, Dalton TP, Stuart GW, and Nebert DW (2000) Transgenic zebrafish
as sentinels for aquatic pollution. Ann N Y Acad Sci 919:133–147.
Clarke DJ, Burchell B, and George SG (1992) Functional and immunochemical
comparison of hepatic UDP-glucuronosyltransferases in a piscine and a mamma-
lian species. Comp Biochem Physiol B 102:425–432.
Dutton GJ (1980) Glucuronidation of Drugs and Other Compounds, CRC Press, Boca
Raton, FL.
Eadie GS (1942) The inhibition of cholinesterase by physostigmine and prostigmine.
J Biol Chem 146:85–93.
Emi Y, Ikushiro S, and Iyanagi T (1995) Drug-responsive and tissue-specific alter-
native expression of multiple first exons in rat UDP-glucuronosyltransferase
family 1 (UGT1) gene complex. J Biochem 117:392–399.
Goldstone JV, McArthur AG, Kubota A, Zanette J, Parente T, Jönsson ME, Nelson
DR, and Stegeman JJ (2010) Identification and developmental expression of the
full complement of Cytochrome P450 genes in Zebrafish. BMC Genomics 11:643.
Harada H, Endo T, Momose Y, and Kusama H (2009) A liquid chromatography/
tandem mass spectrometry method for detecting UGT-mediated bioactivation of
drugs as their N-acetylcysteine adducts in human liver microsomes. Rapid Com-
mun Mass Spectrom 23:564–570.
Hill AJ, Teraoka H, Heideman W, and Peterson RE (2005) Zebrafish as a model
vertebrate for investigating chemical toxicity. Toxicol Sci 86:6–19.
Hill AV (1910) The possible effects of the aggregation of the molecules of haemoglobin
on its dissociation curves. J Physiol 40 (Suppl):4–7.
Hofstee BH (1959) Non-inverted versus inverted plots in enzyme kinetics. Nature
184:1296–1298.
Houston JB and Kenworthy KE (2000) In vitro-in vivo scaling of CYP kinetic data not
consistent with the classical Michaelis-Menten model. Drug Metab Dispos 28:
246–254.
Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, and vom Saal FS (1999)
Exposure to bisphenol A advances puberty. Nature 401:763–764.
Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE,
Humphray S, McLaren K, and Matthews L et al. (2013) The zebrafish reference
genome sequence and its relationship to the human genome. Nature 496:498–503.
Huang H and Wu Q (2010) Cloning and comparative analyses of the zebrafish Ugt
repertoire reveal its evolutionary diversity. PLoS ONE 5:e9144.
James MO (2011) Steroid catabolism in marine and freshwater fish. J Steroid Bio-
chem Mol Biol 127:167–175.
Kaivosaari S, Finel M, and Koskinen M (2011) N-glucuronidation of drugs and other
xenobiotics by human and animal UDP-glucuronosyltransferases. Xenobiotica 41:
652–669.
Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, Ito M, Maruo Y, Sato H,
Yasuda T, and Mita S et al. (2004) A novel mechanism for the inhibition of hyal-
uronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279:33281–33289.
King C, Tang W, Ngui J, Tephly T, and Braun M (2001) Characterization of rat and
human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation
of diclofenac. Toxicol Sci 61:49–53.
Li C and Wu Q (2007) Adaptive evolution of multiple-variable exons and structural
diversity of drug-metabolizing enzymes. BMC Evol Biol 7:69.
LiCata VJ and Allewell NM (1997) Is substrate inhibition a consequence of allostery
in aspartate transcarbamylase? Biophys Chem 64:225–234.
Luukkanen L, Taskinen J, Kurkela M, Kostiainen R, Hirvonen J, and Finel M
(2005) Kinetic characterization of the 1A subfamily of recombinant human
UDP-glucuronosyltransferases. Drug Metab Dispos 33:1017–1026.
Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, Miners
JO, Owens IS, and Nebert DW (2005) Nomenclature update for the mammalian
UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:
677–685.
Maitland ML, Grimsley C, Kuttab-Boulos H, Witonsky D, Kasza KE, Yang L, Roe BA,
and Di Rienzo A (2006) Comparative genomics analysis of human sequence vari-
ation in the UGT1A gene cluster. Pharmacogenomics J 6:52–62.
Meech R, Miners JO, Lewis BC, and Mackenzie PI (2012) The glycosidation of
xenobiotics and endogenous compounds: versatility and redundancy in the UDP
glycosyltransferase superfamily. Pharmacol Ther 134:200–218.